9.8
Mejora de la biodisponibilidad: determinación y enfoques conceptuales para superar los problemas de biodisponibilidad
La biodisponibilidad es un concepto farmacológico esencial que mide la magnitud y la velocidad con la que un principio activo o una fracción terapéuti…
La biodisponibilidad se refiere a la cantidad de fármaco inalterado que llega a la circulación sistémica.
Los medicamentos se clasifican bajo el sistema de clasificación biofarmacéutica en cuatro clases según su solubilidad y permeabilidad.
La solubilidad del fármaco se puede determinar mediante perfiles de solubilidad de pH y métodos de agitación o titulación.
Mientras tanto, los métodos de determinación de la permeabilidad incluyen estudios farmacocinéticos de balance de masas, estudios de perfusión intestinal in vivo y experimentos de permeación con tejido intestinal o monocapas de células epiteliales.
Algunos medicamentos con baja solubilidad y permeabilidad tienen una biodisponibilidad deficiente, que puede superarse mediante enfoques farmacéuticos, farmacocinéticos y biológicos.
El enfoque farmacéutico implica modificar la formulación, el proceso de fabricación o las propiedades fisicoquímicas sin cambiar la estructura química del medicamento.
El enfoque farmacocinético modifica la estructura química del fármaco mediante diseños de profármacos o el desarrollo de nuevas entidades químicas.
El enfoque biológico implica cambiar la vía de administración del fármaco, como cambiar de vía oral a parenteral.
View the full transcript and gain access to JoVE Core videos
Q1: What does bioavailability measure in pharmacology?
Bioavailability measures the amount of unchanged drug reaching the systemic circulation after administration. It reflects both the extent and rate at which an active drug ingredient enters the bloodstream, remaining chemically unchanged. This metric is critical for determining a drug's efficacy and safety profile in patients.
Q2: How does the Biopharmaceutics Classification System categorize drugs?
The Biopharmaceutics Classification System categorizes drugs into four classes based on their solubility and permeability characteristics. This classification system aids in understanding drug absorption characteristics and guiding formulation strategies. Drugs with low solubility and permeability often face challenges with poor bioavailability that require targeted enhancement approaches.
Q3: What methods are used to determine drug solubility?
Drug solubility is determined using pH-solubility profiling, which examines how solubility changes with pH, and shake-flask or titration methods, which determine solubility in different solvents or at various pH levels. These techniques help predict a drug's absorption characteristics and guide formulation development strategies for improving bioavailability.
Q4: What are the main approaches to overcome poor drug bioavailability?
Three primary approaches address poor bioavailability: the pharmaceutical approach modifies formulation, manufacturing, or physicochemical properties without changing chemical structure; the pharmacokinetic approach modifies the drug's chemical structure through prodrug designs or new chemical entities; and the biological approach changes the route of administration, such as switching from oral to parenteral routes.
Q5: How is drug permeability evaluated in bioavailability studies?
Permeability is evaluated through mass-balance pharmacokinetic studies, in vivo intestinal perfusion studies, and permeation experiments using intestinal tissue or epithelial cell monolayers. These methods help predict a drug's absorption and bioavailability by assessing how effectively the drug crosses biological membranes in the gastrointestinal tract.
Q6: What is the pharmaceutical approach to enhancing bioavailability?
The pharmaceutical approach alters the drug's formulation, manufacturing process, or physicochemical properties without changing the molecular structure. This strategy can involve using solubilizers, reducing particle size, or forming amorphous solids to improve drug dissolution and absorption, thereby enhancing bioavailability without modifying the active ingredient itself.
Q7: How does the biological approach improve drug bioavailability?
The biological approach explores alternative routes of administration to bypass limitations associated with oral bioavailability. Switching from an oral to a parenteral route allows the drug to be administered directly into the systemic circulation, avoiding the gastrointestinal tract and its absorption barriers, thereby improving overall drug bioavailability and therapeutic effectiveness.